BaroFold Licenses Technology to Boehringer Ingelheim and Nuron

November 16, 2012

BaroFold Inc., a pharmaceutical company focused on the patented Pressure Enabled Protein Manufacturing (PreEMT) technology invented in the labs of ChBE Professor Theodore Randolph and Dr. John Carpenter, has recently licensed its technology to both Boehringer Ingelheim and Nuron Biotech.  Read more about these collaborative efforts below:

Boehringer Ingelheim and BaroFold Announce Strategic Agreement on PreEMT™ High Pressure Protein Refolding Technology

and

Nuron Biotech Completes Enrollment of a Pivotal Phase 3 Study for Proprietary Recombinant Human Interferon Beta-1b (NU100) in Relapsing Remitting Multiple Sclerosis

News, Technology transfer